Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CARTO™ 3 EP Navigation System V9.0 with PIU Plus

K-Number: K254085 · 2026-01-18

Decision Date2026-01-18
Product CodeDQK
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

CARTO™ 3 EP Navigation System V9.0 with PIU Plus is a medical device manufactured by Biosense Webster, Inc.. It received FDA 510(k) clearance on 2026-01-18 under approval number K254085. The device is classified under product code DQK. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CARTO™ 3 EP Navigation System V9.0 with PIU Plus?

CARTO™ 3 EP Navigation System V9.0 with PIU Plus is a medical device that received FDA 510(k) clearance on 2026-01-18. It is manufactured by Biosense Webster, Inc.. The 510(k) number is K254085.

When was CARTO™ 3 EP Navigation System V9.0 with PIU Plus approved by the FDA?

CARTO™ 3 EP Navigation System V9.0 with PIU Plus received FDA 510(k) clearance on 2026-01-18, under approval number K254085.

What company makes CARTO™ 3 EP Navigation System V9.0 with PIU Plus?

CARTO™ 3 EP Navigation System V9.0 with PIU Plus is manufactured by Biosense Webster, Inc..

What is the FDA product code for CARTO™ 3 EP Navigation System V9.0 with PIU Plus?

The FDA product code for CARTO™ 3 EP Navigation System V9.0 with PIU Plus is DQK.

Related Clinical Trials

Related PubMed Literature

Other Devices by Biosense Webster, Inc.

View all 33 devices →

Related Devices (Code: DQK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.